PortfoliosLab logoPortfoliosLab logo
INZY vs. ARDX
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

INZY vs. ARDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inozyme Pharma, Inc. (INZY) and Ardelyx, Inc. (ARDX). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

INZY vs. ARDX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
INZY
Inozyme Pharma, Inc.
0.00%44.40%-34.98%305.71%-84.60%-66.96%17.67%
ARDX
Ardelyx, Inc.
4.80%14.99%-18.23%117.54%159.09%-83.00%2.37%

Fundamentals

Total Revenue (TTM)

INZY:

$0.00

ARDX:

$407.32M

Gross Profit (TTM)

INZY:

$0.00

ARDX:

$367.78M

EBITDA (TTM)

INZY:

-$100.34M

ARDX:

-$33.44M

Returns By Period


INZY

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

ARDX

1D
2.00%
1M
-5.56%
YTD
4.80%
6M
13.99%
1Y
27.56%
3Y*
8.45%
5Y*
-2.29%
10Y*
-2.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Inozyme Pharma, Inc.

Ardelyx, Inc.

Return for Risk

INZY vs. ARDX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INZY

ARDX
ARDX Risk / Return Rank: 5656
Overall Rank
ARDX Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
ARDX Sortino Ratio Rank: 5757
Sortino Ratio Rank
ARDX Omega Ratio Rank: 5757
Omega Ratio Rank
ARDX Calmar Ratio Rank: 5454
Calmar Ratio Rank
ARDX Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INZY vs. ARDX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inozyme Pharma, Inc. (INZY) and Ardelyx, Inc. (ARDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

INZY vs. ARDX - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


INZYARDXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.40

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.03

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.08

Correlation

The correlation between INZY and ARDX is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

INZY vs. ARDX - Dividend Comparison

Neither INZY nor ARDX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

INZY vs. ARDX - Drawdown Comparison


Loading graphics...

Drawdown Indicators


INZYARDXDifference

Max Drawdown

Largest peak-to-trough decline

-98.45%

Max Drawdown (1Y)

Largest decline over 1 year

-40.42%

Max Drawdown (5Y)

Largest decline over 5 years

-94.32%

Max Drawdown (10Y)

Largest decline over 10 years

-96.82%

Current Drawdown

Current decline from peak

-81.42%

Average Drawdown

Average peak-to-trough decline

-77.32%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.48%

Volatility

INZY vs. ARDX - Volatility Comparison


Loading graphics...

Volatility by Period


INZYARDXDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.78%

Volatility (6M)

Calculated over the trailing 6-month period

50.11%

Volatility (1Y)

Calculated over the trailing 1-year period

69.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

89.97%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

84.26%

Financials

INZY vs. ARDX - Financials Comparison

This section allows you to compare key financial metrics between Inozyme Pharma, Inc. and Ardelyx, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00M120.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
125.22M
(INZY) Total Revenue
(ARDX) Total Revenue
Values in USD except per share items